Open Access DOI:10.23937/2377-4630/2/4/1038
The Effect of Perioperative Restrictive Fluid Therapy on Postoperative Edema and Ecchymosis in Rhinoplasty
Erden V, Sever E, Dagdelen S, Guler C, Kirgezen T, Toprak N and Yigit O
Article Type: Original Research Article | First Published: December 22, 2015
Postoperative edema and ecchymosis can usually occur after rhinoplasty and can cause disgruntled results which influence the satisfaction of patient and surgeon. Prolonged periorbital ecchymosis and severe edema may cause a delay in healing and affect the result of surgery. Many of agents have been used to reduce the influence of edema and ecchymosis developing around the eyes after rhinoplasty, such as corticosteroids, lidocaine and adrenaline combination, melilotus extract....
Open Access DOI:10.23937/2377-4630/2/4/1037
Use of Human Fibrinogen Concentrate in Pediatric Cardiac Surgery Patients
Christopher F. Tirotta, Richard G. Lagueruela, Danielle Madril, Jorge Ojito, Chelsea Balli, Evelio Velis, Marilyn Torres, Francisco Alonso, Robert Hannan and Redmond P. Burke
Article Type: Original Research Article | First Published: December 21, 2015
Bleeding after cardiac surgery can cause increased morbidity and mortality. This is a particularly serious problem in pediatric patients, especially neonates and infants, who may receive multiple units of blood products intra- and postoperatively. The aim of this study is to demonstrate that the use of human fibrinogen concentrate (HFC) during cardiopulmonary bypass (CPB) decreased operative blood loss and the need for perioperative blood component therapy in neonatal, infant and other high-risk...
Open Access DOI:10.23937/2377-4630/2/4/1035
Severe Respiratory Suppression Secondary to Buprenorphine Treated with Volume Assured Pressure Support (VAPS)
Robert J Farney, Boaz Markewitz, Amanda M McDonald and Jill Rhead
Article Type: Case Report | First Published: November 16, 2015
The optimal therapy of chronic opioid induced sleep disordered breathing (SDB) is unclear. Supplemental oxygen may potentially prolong central apneas and increase respiratory suppression. Continuous positive airway pressure (CPAP) is generally ineffective or may even augment central apneas. Therapy with an Adaptive Servo-Ventilation (ASV) device is the most successful option for most etiologies of central apnea including opioids, but we have observed a subpopulation with OISDB that do not respon...
